Cellect Biotechnology
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
23 Hata As St, Kfar Saba, Central Distri...Phone Number
+972 99741444Website
www.cellect.coRevenue
$7.1 MillionStock Symbol
APOPIndustry
About Cellect Biotechnology
Cellect Biotechnology Org Chart
Is Cellect Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cellect Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cellect Biotechnology
Website visits: Recent activity has been detected on your website
Click to see if Cellect Biotechnology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cellect Biotechnology has new funding data
Product Launch: Get notified when Cellect Biotechnology launches new products
Cellect Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cellect Biotechnology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cellect Biotechnology is spiking on competitors!
Recommended Actions
Find VP level buyers at Cellect Biotechnology
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cellect Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellect Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellect Biotechnology.
Cellect Biotechnology Tech Stack
A closer look at the technologies used by Cellect Biotechnology
Cellect Biotechnology News & Media
Why Cellect Biotechnology Shares Are Rising Today
Cellect Biotechnology Ltd (NASDAQ: APOP) is trading higher Monday after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. read moreCellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 26, 2021, including the sale of the Company’s subsidiary, Cellect Biotherapeutics Ltd, to EnCellX Inc. ,Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.
Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellXCellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellect Biotechnology
Cellect Biotechnology (APOP) has developed a breakthrough technology for the selection of stem cells from any given tissue that aims to improve a variety of cell-based therapies. The Company's technology is expected to provide researchers, clinical community, and pharma companies with the tools to rapidly isolate specific cells in quantity and qual... Read More
